DUBLIN--(BUSINESS WIRE)--The "Infection Control Market by Product [Sterilization (Steam, Hydrogen Peroxide, EtO), Disinfection (Wipes, Liquids, Disinfectors), Services, E-Beam, Face Masks], End User (Hospitals, Pharmaceutical Companies), COVID-19 Impact - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

The global infection control market is projected to reach USD 52.7 billion by 2026 from USD 44.7 billion in 2021, at a CAGR of 3.4% during the forecast period.

Growth in the infection control market can largely be attributed to factors such as the high incidence of hospital-acquired infections; the increasing number of surgical procedures; the growing geriatric population and increasing incidence of chronic diseases; the growing focus on food sterilization and disinfection; technological advancements in sterilization equipment; and the increasing outsourcing of sterilization services among pharmaceutical companies, hospitals, and medical device manufacturers. Currently, with the surge in cases of COVID-19, there is an increasing focus on personal hygiene and increasing production of medical nonwovens and single-use products, such as face masks and gloves. This, in turn, is expected to propel market growth in the next two years.

On the other hand, concerns regarding the safety of reprocessed instruments are expected to limit market growth to some extent in the coming years. This, along with factors such as the high cost of endoscope reprocessing, limited reimbursement in developing countries, and end-user non-compliance with sterilization standards, may hamper the growth of the market.

Based on end-user, the hospitals' segment is expected to register the highest CAGR during the forecast period.

Based on end-user, the infection control market is segmented into hospitals & clinics, medical device companies, pharmaceutical companies, life science industry, food industry, and other end users (cosmetic industry, dietary supplement manufacturers, the veterinary industry, and other healthcare providers such as long-term care facilities and diagnostic & imaging centers). The hospitals & clinics segment is expected to grow at the highest CAGR during the forecast period. The overall demand for infection control in hospitals is largely driven by the increasing prevalence of HAIs, the increasing number of hospitals and clinics worldwide, and the rising geriatric population (as this population segment is more susceptible to various chronic diseases). The growing volume of surgical procedures performed is also expected to propel market growth.

North America is expected to account for the largest share of the infection control market in 2020.

In 2020, North America accounted for the largest share of the infection control market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The region's large share can be attributed to the growing demand for and adoption of sterilization and disinfection products along with services as a result of the rising focus on healthy lifestyles and disease prevention among consumers. The surge in the geriatric population in the coming years and the subsequent increase in the prevalence of chronic diseases, the need for infection control to minimize the prevalence of HAIs, and implementation of favorable government initiatives and stringent regulations on sterilization and disinfection are also propelling the infection control market in the region.

Market Dynamics

Drivers

• High Incidence of Hospital-Acquired Infections (Hais)
• Increasing Number of Surgical Procedures
• Growing Geriatric Population and the Increasing Incidence of Chronic Diseases
• Growing Focus on Food Sterilization and Disinfection
• Technological Advancements in Sterilization Equipment
• Increasing Outsourcing of Sterilization Services Among Pharmaceutical Companies, Hospitals, and Medical Device Manufacturers
• Growing Awareness of Environmental & Personal Hygiene due to COVID-19

Restraints

• Concerns Regarding the Safety of Reprocessed Instruments
• Adverse Effects of Chemical Disinfectants
• High Cost of Endoscopy Reprocessing and Limited Reimbursement in Developing Countries

Opportunities

• Growing Medical Device and Pharmaceutical Companies in Emerging Economies
• Increasing Use of E-Beam Sterilization
• Reintroduction of Ethylene Oxide Sterilization
• Rising Adoption of Single-Use Medical Nonwovens and Devices
• Growing Healthcare Industry and Outsourcing of Operations to Emerging Countries

Challenges

• Sterilization and Disinfection of Advanced Medical Instruments
• End-User Noncompliance with Sterilization Standards
• Development of Alternative Technologies for Surface Disinfection

Companies Mentioned

• 3M Company
• Advanced Sterilization Products (ASP)
• Belimed AG (A Subsidiary of Metall Zug Group)
• C.B.M. S.R.L. Medical Equipment
• Cantel Medical
• Contec, Inc.
• Continental Equipment Company
• Ecolab Inc.
• Getinge Ab
• Matachana Group
• Medalkan
• Melag Medizintechnik GmbH & Co. Kg
• Metrex Research LLC (A Subsidiary of Danaher Corporation)
• MMM Group
• Pal International
• Reckitt Benckiser
• Sotera Health Company
• Steris plc
• Systec GmbH
• The Miele Group

For more information about this report visit https://www.researchandmarkets.com/r/inzpu1

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900